Name and address of the site: Medac Gesellschaft fuer klinische Spezialpraeparate m.b.H
, Theaterstrasse 6, Wedel, Schleswig-Holstein, 22880, Germany
1. MEDICINAL PRODUCTS
1.1. with a Marketing Authorisation in EEA country(s)
1.3. without a Marketing Authorisation in the EEA and intended for exportation
|
2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS
2.1. Procurement
2.2. Holding
2.3. Supply
2.4. Export
|
3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS
3.1.1. Narcotic or psychotropic products
3.3. Cold chain products(requiring low temperature handling)
|
Any restrictions or clarifying remarks (for all users): National legal basis of authorisation: § 52a Section 1 of German Drug Law (Arzneimittelgesetz)
Name and address of the site: Medac Gesellschaft fuer klinische Spezialpraeparate m.b.H.
, Wilfried-Mohr-Strasse 1-5, Tornesch, Schleswig-Holstein, 25436, Germany
1. MEDICINAL PRODUCTS
1.1. with a Marketing Authorisation in EEA country(s)
1.3. without a Marketing Authorisation in the EEA and intended for exportation
|
2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS
2.1. Procurement
2.2. Holding
2.3. Supply
2.4. Export
|
3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS
3.1.1. Narcotic or psychotropic products
3.3. Cold chain products(requiring low temperature handling)
|
Any restrictions or clarifying remarks (for all users): National legal basis of authorisation: § 52a Section 1 of German Drug Law (Arzneimittelgesetz)
Name and address of the site: Medac Gesellschaft für klinische Spezialpräparate m.b.H.
, Werner-von-Siemens-Straße 6, Elmshorn, 25337, Germany
1. MEDICINAL PRODUCTS
1.1. with a Marketing Authorisation in EEA country(s)
1.3. without a Marketing Authorisation in the EEA and intended for exportation
|
2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS
2.2. Holding
|
3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS
3.1.1. Narcotic or psychotropic products
3.3. Cold chain products(requiring low temperature handling)
|
Any restrictions or clarifying remarks (for all users): National legal basis of authorisation: § 52a Section 1 of German Drug Law (Arzneimittelgesetz)
*Art 5 of Directive 2001/83/EC or Art 83 of Regulation EC/726/2004
**Without prejudice to further authorisations as may be required according to national legislation
|